Search Results - "SOLEM, C. T."

Prioritizing Comparative‐Effectiveness Research Topics via Stakeholder Involvement: An Application in COPD by Pickard, A S, Lee, T A, Solem, C T, Joo, M J, Schumock, G T, Krishnan, J A

“…A major priority for funding agencies and researchers involved in comparative‐effectiveness research (CER) is to ensure that research questions will produce…”
Get full text

Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections by Nathwani, D., Eckmann, C., Lawson, W., Stephens, J.M., Macahilig, C., Solem, C.T., Simoneau, D., Chambers, R., Li, J.Z., Haider, S.

“…The objective of this study was to document pan-European real-world treatment patterns and healthcare resource use and estimate opportunities for early switch…”
Get full text

Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A by LEISSINGER, C., COOPER, D. L., SOLEM, C. T.

“…Few data exist on the impact of age and inhibitor status on activity levels among patients with severe and moderately severe haemophilia A. The aim of this…”
Get full text

Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective by Rello, J, Nieto, M, Solé-Violán, J, Wan, Y, Gao, X, Solem, C.T, De Salas-Cansado, M, Mesa, F, Charbonneau, C, Chastre, J

“…Abstract Objectives Adopting a unique Spanish perspective, this study aims to assess healthcare resource utilization (HCRU) and the costs of treating…”
Get full text

Resource Utilization Among Advanced Squamous and non-Squamous non-Small Cell Lung Cancer Patients Receiving Second-Line Treatment in France, Germany, Italy, and Spain: Results of A Retrospective Medical Chart Review by Solem, CT, Penrod, JR, Lees, M, Manley Daumont, M, Macahilig, CP, Baeten, S, Verleger, K, Wilke, T

Get full text

Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A: AGE, INHIBITORS AND FUNCTIONAL LIMITATIONS by LEISSINGER, C., COOPER, D. L., SOLEM, C. T.

Get full text

Impact of Pulmonary Exacerbations On Eq-5d Measures In Patients With Cystic Fibrosis by Solem, C.T, Vera-Llonch, M, Liu, S, Botteman, M, Lin, F.J, Castiglione, B

Get full text

Early Switch/Early Discharge Opportunities for Hospitalized Patients with Methicillin-Resistant Staphylococcus Aureus Complicated Skin And Soft Tissue Infections: Proof Of Concept in the United Arab Emirates by El Houfi, A, Javed, N, Nathwani, D, Solem, C.T, Macahilig, C.P, Stephens, J.M, Raghubir, N, Hájek, P, Li, J.Z, Haider, S

Get full text

PRS40 - Pulmonary Exacerbations, Lung Dysfunction, And Eq-5d Measures In Adolescents And Adults With Cystic Fibrosis And Homozygous For The F508del-Cftr Mutation by Solem, CT, Vera-Llonch, M, Tai, M, O’Callaghan, L

Get full text

Pulmonary Exacerbations, Lung Dysfunction, And Eq-5d Measures In Adolescents And Adults With Cystic Fibrosis And Homozygous For The F508del-Cftr Mutation by Solem, CT, Vera-Llonch, M, Tai, M, O’Callaghan, L

Get full text

Methods For The Design And Conduct Of Medical Record Reviews In Oncology by Wilke, T, Baeten, S, Solem, CT, Penrod, JR, Verleger, K, Lees, M, Manley Daumont, M

Get full text

PRM220 - Methods For The Design And Conduct Of Medical Record Reviews In Oncology by Wilke, T, Baeten, S, Solem, CT, Penrod, JR, Verleger, K, Lees, M, Manley Daumont, M

Get full text

PCN109 - Real-World Health Care Resource Utilization and Related Costs Among Patients Who Received At Least Two Lines of Treatment for Advanced Nsclc in England, The Netherlands, and Sweden by Solem, CT, Penrod, JR, Lees, M, Macahilig, C, Luo, L, Verleger, K, Manley Daumont, M, Hertel, N

Get full text

Real-World Health Care Resource Utilization and Related Costs Among Patients Who Received At Least Two Lines of Treatment for Advanced Nsclc in England, The Netherlands, and Sweden by Solem, CT, Penrod, JR, Lees, M, Macahilig, C, Luo, L, Verleger, K, Manley Daumont, M, Hertel, N

“…OBJECTIVES: Advanced (stage IIIb/IV) non-small cell lung cancer (aNSCLC) presents a high burden to society. This study aimed to quantify real-world health care…”
Get full text

Cost Drivers of Lung Cancer Care: Results From A Retrospective Chart Review of Pretreated Advanced Nsclc Patients in Europe by Solem, CT, Penrod, JR, Lees, M, Macahilig, C, Luo, L, Verleger, K, Manley Daumont, M, Hertel, N

“…OBJECTIVES: Advanced (stage IIIb/IV) non-small cell lung cancer (aNSCLC) has a significant economic impact on society. This 7-country European study describes…”
Get full text

PCN111 - Cost Drivers of Lung Cancer Care: Results From A Retrospective Chart Review of Pretreated Advanced Nsclc Patients in Europe by Solem, CT, Penrod, JR, Lees, M, Macahilig, C, Luo, L, Verleger, K, Manley Daumont, M, Hertel, N

Get full text

Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease by Solem, Caitlyn T, Sun, Shawn X, Sudharshan, Lavanya, Macahilig, Cynthia, Katyal, Monica, Gao, Xin

“…Exacerbation-associated health-related quality of life (HRQoL) in patients with severe and very severe chronic obstructive pulmonary disease (COPD) is…”
Get full text

PCN117 - Resource Utilization Among Advanced Squamous and non-Squamous non-Small Cell Lung Cancer Patients Receiving Second-Line Treatment in France, Germany, Italy, and Spain: Results of A Retrospective Medical Chart Review by Solem, CT, Penrod, JR, Lees, M, Manley Daumont, M, Macahilig, CP, Baeten, S, Verleger, K, Wilke, T

Get full text

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis by Shelbaya, Ahmed, Solem, Caitlyn T, Walker, Chris, Wan, Yin, Johnson, Courtney, Cappelleri, Joseph C

“…This study aimed to evaluate the characteristics associated with early versus late initiation of celecoxib treatment after osteoarthritis (OA) diagnosis and…”
Get full text

Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study by Dhanda, Rahul, Varghese, Della, Nadipelli, Vijay R, Fava, Maurizio, Joshi, Namita, Solem, Caitlyn T, Graham, James A, Learned, Susan M, Heidbreder, Christian

“…RBP-7000 (PERSERIS™) is a once-monthly subcutaneous extended-release risperidone formulation approved by the United States Food and Drug Administration for the…”
Get full text